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Abstract
Imaging is a helpful tool for clinicians to evaluate diseases that
induce chronic joint inflammation. Chronic gout is associated with
changes in joint structures that may be evaluated with diverse
imaging techniques. Plain radiographs show typical changes only
in advanced chronic gout. Computed tomography may best
evaluate bone changes, whereas magnetic resonance imaging is
suitable to evaluate soft tissues, synovial membrane thickness, and
inflammatory changes. Ultrasonography is a tool that may be used
in the clinical setting, allowing evaluation of cartilage, soft tissues,
urate crystal deposition, and synovial membrane inflammation. Also
ultrasound-guided puncture may be useful for obtaining samples
for crystal observation. Any of these techniques deserve some
consideration for feasibility and implementation both in clinical
practice and as outcome measures for clinical trials. In clinical
practice they may be considered mainly for evaluating the
presence and extent of crystal deposition, and structural changes
that may impair function or functional outcomes, and also to
monitor the response to urate-lowering therapy.
Introduction
Gout is a disease caused by deposition of monosodium urate
(MSU) monohydrate crystals that induce not only acute
episodes of inflammation, but also, in the long-term history of
the disease, chronic inflammation that is associated with
changes in articular and periarticular structures. Imaging may
be useful to evaluate the severity of disease (measurement of
structural joint changes), the extent of MSU deposition
(location and magnitude of urate deposition), and the
presence of chronic inflammation [1]. In addition, as an
outcome measure, imaging may allow estimation of the
change of these variables during urate-lowering therapy; that
is, as MSU crystals dissolute due to the long-term effect of
subsaturating serum urate levels achieved during urate-
lowering therapy [2]. If so, imaging would also provide a useful
tool to monitor the response to urate-lowering therapy [3,4].
Plain radiography
Findings
In patients with the very first manifestations of gout, no
radiographic findings are present but for an increase in the
soft tissues. Typical plain radiographic features of chronic
gout [5] include visualization of tophi as soft-tissue or
intraosseous masses, and the presence of a nondeminerali-
zing erosive arthropathy with erosions that are well defined
with sclerotic or overhanging margins (Figure 1a). The joint
space is usually preserved until late in the disease, and other
features such as periosteal new bone formation, extra-
articular erosions, intraosseous calcifications (Figure 1b),
joint space widening, and subchondral collapse may be
present [6-8]. Radiographic abnormalities are most frequently
present in the feet (Figure 1b), particularly in the first meta-
tarsal phalangeal joint [8]. Radiographic damage is a late
feature of chronic gout, typically occurring 15 years after
onset of the disease, and is virtually always present in
patients with subcutaneous tophi [5]. Oblique projections
may enhance observation of small erosions (Figure 1c).
Plain radiography to evaluate severity
A recent study has identified a valid radiographic damage
index in chronic gout. Such a scoring system is required for
future studies to determine the impact of intensive urate-
lowering on radiographic damage, and to guide therapeutic
decision-making in patients with chronic gout. The gout
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radiographic damage index is a modified Sharp/van der
Heijde scoring method of erosion and joint space narrowing,
which incorporates the joints scored in the rheumatoid
arthritis scoring method and the hand distal interphalangeal
joints. This index was shown to be reproducible, feasible, and
able to discriminate between early and late disease [9]. This
damage index has shown to be strongly associated with
functional capacity [10].
A comparison of plain radiography and computed tomo-
graphy (CT) has shown very good agreement between the
two methods for assessment of gouty erosions, providing
further validation for the erosion component of the gout radio-
graphic damage index [11]. Some mismatch was evident,
however, with higher radiographic erosion scores at the distal
interphalangeal joints. It is probable that assessment of these
joints for erosion by plain radiography may be less reliable
due to their small size, and due to the presence of concurrent
degenerative joint disease.
Computed tomography
CT allows excellent visualization of tophi (Figure 2). MSU
crystals obtained from tophi measure around 170 Hounsfield
units, and similar densities ranging from 150 to 200
Hounsfield units are measured in subcutaneous and intra-
articular tophi [11]. Use of CT may assist in differentiating tophi
from other subcutaneous nodules. Gerster and colleagues
have suggested that CT provides more specific images than
ultrasonography or magnetic resonance imaging (MRI) for
assessment of tophi [12].
CT has the potential to play a role in clinical assessment of
chronic gout in a number of situations; in assessing compli-
cations of gout [13,14], in guiding aspiration, in assisting with
noninvasive diagnosis of subcutaneous nodules, in
identification of deep intra-articular tophi, and in evaluation of
bone erosion associated with gout.
CT for bone change evaluation in gout
CT has superior capability over both plain radiography and
MRI to detect bone erosion in other erosive arthropathies
such as rheumatoid arthritis [14,15]. The excellent ability of
this imaging modality to image both tophus and bone erosion
has provided new insights into mechanisms of joint damage
in chronic gout.
A systematic CT analysis of individual joints in patients with
chronic gout has demonstrated a strong relationship between
bone erosion and intraosseous tophus [10]. For those joints
with bone erosion on CT, 81.8% had visible intraosseous
tophus, and all joints with large erosions (>7.5 mm diameter)
had visible intraosseous tophus. There was also a strong
correlation between the CT erosion diameter and the intra-
osseous tophus diameter in individual joints (r = 0.92,
P <0.0001). Intraosseous tophi were larger than nonintra-
osseous tophi, but had similar density and calcification,
suggesting that the burden of MSU crystals within the joint,
rather than particular biological characteristics of the tophus,
is an important determinant of the development of associated
bone erosion in gout. Direct visualization of tophi within sites
of erosion strongly implicates these lesions as causative in the
pathogenesis of bone erosion in gout, and provides further
support for early urate-lowering therapy, in order to prevent
the development of intraosseous tophi and bone erosion.
CT to evaluate monosodium urate crystal deposition
A further development in CT imaging of gout is the use of
dual-energy CT; a system with two X-ray tubes scanning at
Figure 1
Plain radiography images demonstrating bone erosions. (a) Radiography of the hand in an oblique projection demonstrating bone erosions located
in metacarpal phalangeal joints and in proximal and distal interphalangeal joints. (b) Radiography of the foot in a dorsal–plantar projection showing
extensive bone erosions involving the first and fifth metatarsal phalangeal joints, and proximal and distal interphalangeal joints. Typical intratophus
calcifications may be seen in intraosseous tophi and in periarticular tophi. (c) Radiography of the tarsal bones in an oblique projection showing
erosions in the scaphoid and first metatarsal bone, with typical overhanging edges. Soft-tissue masses due to extensive tophaceous deposition
may also be observed.80 kbp and 140 kbp. This technology has been used for
compositional analysis of kidney stones and allows for colour
identification of uric acid and calcium. Dual-energy CT has
the potential to allow noninvasive diagnosis of gout, and also
measurement of total body urate burden, through three-
dimensional volume assessment of tophi [15,16]. Validation
studies are now needed to confirm the specificity and
reliability of this technique, particularly compared with other
methods of tophus assessment.
Magnetic resonance imaging
Although findings are not specific for the diagnosis of gout,
MRI allows early detection of tophi and bone erosion in
patients with gout [17]. Synovial involvement may also be
appropriately evaluated with MRI [18]. The relative lack of
specificity of MRI and the technique’s high cost, however,
limit its role in routine clinical assessment of gout.
Evaluation of monosodium urate crystal deposition
Chronic tophaceous gout often presents as juxtarticular soft-
tissue masses, sharply defined erosions, overhanging margin
bone, and thickening of the synovium.
Tophi have variable signal intensity on T2-weighted images
(Figure 3a). The most common pattern is heterogeneous
intermediate to low signal intensity on T2-weighted images.
Both the synovial membrane and tophi can show intense
gadolinium enhancement, reflecting granulation tissue and
increased vascularization.
Typically, tophi have homogeneous low signal intensity on T1-
weighted spin-echo images but variable signal intensity on
T2-weighted images. Peripheral enhancement of tophi
following intravenous gadolinium has also been reported [19],
but peripheral enhancement made it difficult to obtain proper
imaging of tophi in one study [20]. In joints affected by tophi,
synovial thickening (Figure 3b), effusions and bone erosion
may be present, with bone marrow oedema adjacent to tophi
[17,19,21]. MRI studies have has also shown that urate
deposits spread along compartmental and fascial planes,
rather than in a radial pattern [17].
Evaluation of synovial involvement in chronic gout
The synovial membrane is generally too thin to be shown by
MRI. The membrane becomes visible when it is pathologically
thickened. In patients with chronic gout a variable signal
intensity pattern may be observed, but most of the time the
membrane shows intermediate to low signal intensity on T2-
weighted images (Figure 3c).
Multiple conditions may illustrate hypointense synovial lesions
on T2-weighted images. Classically pigmented villonodular
synovitis presents as localized or diffuse proliferative hypo-
intense lesions. Other conditions such as haemophilic
arthropathy, amyloid arthropathy, synovial chondromatosis,
and long-standing rheumatoid arthritis [18], and even other
granulomatous diseases such as tuberculosis and fungal
infections, may show similar findings [19].
MRI may have a particular clinical role in identifying complica-
tions of gout. In a series of patients showing unexplained limi-
tation of the knee joint, MRI was useful to evaluate tophaceous
urate deposition as the cause of such limitation [22].
Ultrasonography
Over the past several years there has been growing interest
in ultrasonography (US) in rheumatology [23-25]. Advantages
of using US include the lack of radiation, the low cost
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Figure 2
Computed tomography images demonstrating extensive tophaceous deposits. Three-dimensional volume-rendered computed tomography images
of the right foot from a patient with chronic gout, demonstrating extensive tophaceous deposits (visualized as red) – particularly at the first
metatarsal phalangeal joint, midfoot and Achilles tendon. (a) Dorsal view and (b) lateral view.(compared with MRI and CT), the repeatability, the patient
friendliness, the multiplanar imaging capability, the high
resolution, the dynamic assessment, and its efficacy as a
method of guidance for gold-standard diagnostic procedures
for gout, such as synovial fluid and tophi aspiration.
The physics of US make it an ideal tool to detect crystalline
material in soft tissues. US has long been used to detect
calcified gallstones and renal stones. The technique
visualizes tissues as acoustic reflections. Crystalline material
found in gouty joints reflects ultrasound waves more strongly
than surrounding tissues such as unmineralized hyaline
cartilage or synovial fluid, and can thus be readily distin-
guished.
Ultrasonography findings in early urate deposition
The impact of US has been recently highlighted in patients
with asymptomatic hyperuricemia [26]. Small tophaceous
deposits were found in 12 (34%) of these patients, and an
increased power-Doppler signal was observed in eight (23%)
patients, suggesting onsite inflammation. This study using US
is the first to link the gap between asymptomatic hyper-
uricemia and symptomatic deposition of urate, namely gout.
Could we call this stage asymptomatic deposition of urate or
asymptomatic gout? Imaging showing crystal deposition and
inflammation may support starting urate-lowering therapy,
especially in view of recent reports suggesting that gout may
be a better predictor of cardiovascular outcomes than hyper-
uricemia [27,28].
Comparison of high-resolution US with conventional X-ray
imaging in the metatarsal phalangeal joints of gouty patients
found changes suggesting gout in 22 metatarsal phalangeal
joints in patients with gout who had never been subjected to
an attack of acute gout [29]. Erosions were detected three
times more frequently by high-resolution US than on X-ray
imaging. In this study, US aided in the diagnosis of gout by
identifying sonographic features suggestive of gout in
clinically silent joints.
Another study compared US with conventional radiography
[30]. The hand, finger, and toe joints of 19 patients with acute
and chronic gout were examined with grey-scale and power-
Doppler US. The US technique was found to be superior to
conventional radiographs in evaluating small bone changes.
The authors suggest that power-Doppler US can differentiate
active from inactive, noninflamed fibrotic synovial tissue and
that inflammation in gouty joints is better detected with
power-Doppler US than with clinical examination [30].
In another study comparing high-resolution US with conven-
tional radiography, the authors found conventional radio-
graphy to have a sensitivity of 31% (32/102) and a specificity
of 93% (55/59) in showing features of gout, versus US that
had a sensitivity of 96% (98/102) and a specificity of 73%
(43/59) in showing features of gout [31]. The authors’ con-
clusion was that US was much more sensitive than
conventional X-ray imaging but was less specific.
Ultrasonography images in gout
Several patterns of US have been reported in patients with
gout (Table 1).
The most useful elemental lesion is the double-contour sign –
a hyperechoic, irregular band over the superficial margin of
the joint cartilage, produced by deposition of MSU crystals
on the surface of the hyaline cartilage, which increases the
interface of the cartilage surface, reaching a thickness similar
Arthritis Research & Therapy    Vol 11 No 3 Perez-Ruiz et al.
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Figure 3
T2-weighted magnetic resonance imaging scans. (a) Coronal gradient echo T2-weighted magnetic resonance imaging (MRI): two nodular images
with an intermediate signal (tophi) under the external collateral ligament and inside the posterior cruciate ligament of the knee. An external
meniscus tear may be seen close to urate deposition. (b) Axial T2-weighted MRI: low signal intensity of both tophi, and marked hypointensity of
synovium in a Baker cyst. (c) Axial post-contrast (gadolinium) T1-weighted MRI: thickening and nodular enhancement of the synovium in the
suprapatelar recess.to the subchondral bone (Figure 4a). In a study of US
pictures obtained from 60 patients with a crystal-proven
diagnosis (34 patients with calcium pyrophosphate dihydrate
crystal deposition disease and 26 patients with MSU crystal-
proven gout), MSU crystal deposition was found on the
surface of articular cartilage [32]. The double contour sign
was only found in patients with gout [33].
In contrast to gout, calcium pyrophosphate crystals tend to
aggregate in the middle layer of the hyaline cartilage, parallel
to the bony cortex, as a hyperechoic, irregular line embedded
in the anechoic-appearing hyaline cartilage, with a normal
hyaline cartilage surface [32]. Chondrocalcinosis can thus be
readily distinguished from gout.
Another useful ultrasound sign is the presence of hyper-
echoic cloudy areas in the synovial joint (Figure 4b). The
synovial sheath and soft tissue have 79% sensitivity and 95%
specificity [31]. Bright dotted foci and hyperechoic stippled
aggregates have 80% sensitivity and 75% specificity. The
presence of bright stippled foci and/or hyperechoic areas on
US indicated gout with great sensitivity (96%), whereas the
specificity is limited (73%).
Bone erosions defined by US are defined as breaks in the
hyperechoic bone profile detectable in two perpendicular
planes. Ultrasound has proven to be three times more
sensitive than plain films in the detection of bone erosions
<2 mm (P <0.001) [29].
Another aspect of the use of US was to measure tophi. A
recent study compared the use of MRI with US in evaluating
intraarticular and articular tophi [34]. US detected at least
one tophus in all joints where MRI found nodules considered
to be tophi. Aspiration of nodules suspected as tophi found
MSU crystals in 83%. The study found good correlation, but
only fair agreement, between US and MRI.
There is preliminary evidence to date suggesting that power-
Doppler US may be able to differentiate active, inflamed
synovium from inactive, noninflamed synovium. Recent
reports have shown that the power-Doppler signal is present
Available online http://arthritis-research.com/content/11/3/232
Page 5 of 8
(page number not for citation purposes)
Table 1
Gout ultrasound elemental lesions
Double contour sign
Hyperechoic soft-tissue areas 
Bright dotted foci and hyperechoic stippled aggregates
Snowstorm appearance of synovial fluid
Bone erosions 
Hypervascularization: Doppler signal
Tophi, with or without posterior shadow
Soft-tissue oedema
Figure 4
Ultrasonography patterns indicating the presence of gout. (a) Double
contour sign: transversal ultrasound imaging of the knee joint in the
anterior intercondile area. The double contour image is shown as an
anechoic line paralleling bony contour femoral cartilage. B-mode, linear
transducers with a frequency of 9 MHz. C, knee condyles. (b) Hyper-
echoic images: longitudinal ultrasound imaging of the dorsal aspect of
the first metatarsal phalangeal joint. The hyperechoic cloudy area
represents monosodium urate deposits within the thickened synovial
membrane (arrows). B-mode, linear transducers with a frequency of 9
MHz. MH, metatarsal head. (c) Power-Doppler signal: longitudinal
view, dorsal aspect of an asymptomatic first metatarsal phalangeal
joints. The Doppler signal may be seen even seen in hyperechoic
synovial areas. Transducer with a frequency of 14 MHz in grey scale
and colour Doppler with a frequency of 7.5 MHz.in acutely inflamed joints from gout patients, and that the
power-Doppler signal disappears with treatment [35], which
suggests that power-Doppler US could be a useful method to
monitor gouty synovitis (Figure 4c). Interestingly, other
authors have observed that the power-Doppler signal was
even present in asymptomatic joints from gout patients [33]
and in asymptomatic hyperuricemia [26].
Imaging techniques as outcome measures in
gout
Truth, Discrimination (which includes reliability and sensitivity
to change), and Feasibility  are the cornerstones of the
OMERACT filter for outcome measures in clinical trials.
Although specifically designed for outcome measures in
clinical trials, outcome measures may be implemented – once
one considers that they were developed specifically for
clinical trials – in clinical practice, as occurred for the Disease
Activity Score for rheumatoid arthritis.
Plain radiographs
A modified Sharp/van der Heijde method was compared with
the Ratinger destruction score and the Steinbrocker score to
determine the scoring method that best reflected radio-
graphic changes in chronic gout. The Sharp/van der Heijde
erosion score and the Sharp/van der Heijde joint space
narrowing score independently contributed to the consensus
global score, but agreement was better between the con-
sensus global score and the adjusted Sharp/van der Heijde
erosion plus narrowing score. The authors observed that
most reproducible method was the modified Sharp/van der
Heijde method and that it also best discriminated patients
with longstanding or tophaceous gout [9].
The previous study did not evaluate sensitivity to change. In a
study of 2,000 patients with gout, two or more radiographs of
the same joint were available in 80 patients at intervals
ranging from 3 to 29 years [36]. Radiologic improvement was
observed in only 21 (26%) patients and progressive
deterioration was observed in 41 (51%) cases. Improvement
was only related to soft-tissue swelling, cortical intraosseous
erosions, and lytic lesions, but narrowing of the joint space
was observed to be irreversible.
In another study of 39 patients at 10-year follow-up, radio-
graphic improvement was observed in eight cases (20%), 22
(57%) cases were unchanged, and nine (23%) patients
showed progression of radiographic findings [37]. Interestingly,
1/14 (7%) patients of a group with no radiographic involve-
ment at entrance and an average serum urate during follow-up
of 6.2 mg/dl showed radiographic progression, while 3/11
(27%) patients of a group with previous radiographic involve-
ment but no subcutaneous tophus and an average serum urate
during follow-up of 6.5 mg/dl showed progression, and 5/14
(36%) patients of a group with both radiographic and
tophaceous involvement at entrance and an average serum
urate during follow-up of 7.1 mg/dl showed progression.
Limitations to these studies are that none of them defined
improvement or studied variability in the reading of radio-
graphs, the number of patients was small, and proper control
of urate was not achieved in more than one-half of the
patients.
Tophus measurement as an outcome measure
The MSU (tophus) deposition measurement was included in
the core set of outcome measures of OMERACT7.
Measurement of subcutaneous tophi using a metric belt was
shown to be highly variable, contrary to the measurement
using a calibrated calliper that was shown to be as reliable as
CT [38]. Both methods have been shown sensitive to change
during urate-lowering therapy, but the smallest detectable
difference is high for the metric belt and has not been tested
in a short-term study. Three studies designed to validate the
measurement of tophi with imaging techniques have been
recently published [20,34,38].
The development of advanced three-dimensional modelling
and volume assessment now allows CT technology to be
used to accurately analyse the size of tophaceous nodules.
The reliability of CT measurement of the subcutaneous
tophus volume was compared with physical measurement of
the tophus size using a calibrated calliper [38]. CT measure-
ment of the tophus volume was shown to be highly reliable
and reproducible. There was no difference in reproducibility,
however, between CT and physical measurement with a
calliper. Furthermore, for tophi identified by physical and CT
assessment, there was excellent correlation between
measurements. Therefore, although CT assessment of the
subcutaneous tophus volume is reliable and reproducible,
physical measurement correlates well with CT, has equivalent
reproducibility, and is much more feasible.
MRI assessment of tophus was also studied, showing good
intrareader reproducibility using unenhanced spin-echo
images [20]. The smallest detectable difference was close to
25% of the volume measurement. A small but statistically
significant difference in the inter-reader mean tophus volume
was detected. The sensitivity to change of this method has
not yet been assessed.
US hardware is more easily available than that for CT and
MRI, and therefore US is considered the most feasible,
nonradiating, and least expensive imaging technique. To
evaluate US as an outcome measure with face validity, US-
guided puncture of articular nodules suspected to be tophi
yielded 83% of positive results for MSU crystals [34]. US
was also compared with MRI, showing good correlation but
showing modest agreement for measurement. Volume
measurement reproducibility was good for both intraobserver
and interobserver correlations. Sensitivity to change was also
tested at 12-month follow-up on urate-lowering therapy. In
patients showing serum urate levels <6 mg/dl, 19/28 (68%)
tophi showed a reduction over that of the smallest detectable
Arthritis Research & Therapy    Vol 11 No 3 Perez-Ruiz et al.
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serum urate levels >6 mg/dl showed a significant reduction.
Furthermore, there was an inverse correlation between the
reduction in both diameters and volume and the average
serum urate levels during urate-lowering therapy.
Conclusions
Plain radiographs are less sensitive to early changes in
chronic gout than other imaging techniques. The presence of
structural changes in radiographs correlates with poor
function, and is associated with irreversibility of changes. CT
may be the most specific imaging technique when evaluating
intraosseous lesions, while MRI could be the preferred
technique to evaluate chronic synovial involvement. High-
resolution US may show very early deposition of urate
crystals and may also evaluate synovial thickening and
inflammation, although more studies are needed. US is the
only imaging technique that has been fully validated for tophi
measurement, but further studies must confirm this issue.
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